3.86
+0.0101(+0.26%)
Currency In USD
| Previous Close | 3.85 |
| Open | 3.87 |
| Day High | 3.93 |
| Day Low | 3.84 |
| 52-Week High | 4.39 |
| 52-Week Low | 2.11 |
| Volume | 33,149 |
| Average Volume | 53,759 |
| Market Cap | 326.95M |
| PE | -8.04 |
| EPS | -0.48 |
| Moving Average 50 Days | 3.28 |
| Moving Average 200 Days | 3.06 |
| Change | 0.01 |
If you invested $1000 in Alpha Tau Medical Ltd. (DRTS) since IPO date, it would be worth $382.19 as of September 17, 2025 at a share price of $3.86. Whereas If you bought $1000 worth of Alpha Tau Medical Ltd. (DRTS) shares 3 years ago, it would be worth $636.98 as of September 17, 2025 at a share price of $3.86.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial
GlobeNewswire Inc.
Sep 02, 2025 12:30 PM GMT
– First patient treatment marks successful initiation of multi-center pilot study in Alpha DaRT U.S. pancreatic cancer program – – Study explores Alpha DaRT® combined with chemotherapy in patients with newly diagnosed unresectable locally advanced or
Alpha Tau to Participate in Five September Investor Conferences
GlobeNewswire Inc.
Aug 27, 2025 12:30 PM GMT
JERUSALEM, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will present
Alpha Tau to Present at Jefferies Global Healthcare Conference
GlobeNewswire Inc.
May 28, 2025 12:30 PM GMT
JERUSALEM, May 28, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will present a